Citation Tools

Download PDFPDF

506 Belimumab (BEL) improves renal outcomes in active Lupus Nephritis (LN): a phase 3 randomized, Placebo (PBO)-controlled trial

Download to a citation manager

Cite this article as:
Rovin BH, Houssiau F, Furie R, et al
506 Belimumab (BEL) improves renal outcomes in active Lupus Nephritis (LN): a phase 3 randomized, Placebo (PBO)-controlled trial